Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): Delivery to acute myeloid leukemic blasts using adeno-associated virus

Human Gene Therapy

Volumn 8, Issue 9, 1997, Pages 1125-1135

  Anderson, Robert ^a   Macdonald, Ian ^a   Corbett, Tim ^a   Hacking, Graeme ^a   Lowdell, Mark W ^a   Prentice, H Grant ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GAMMA INTERFERON; HYBRID PROTEIN; INTERLEUKIN 12; PHYTOHEMAGGLUTININ; STAT4 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADENO ASSOCIATED VIRUS; ANIMAL CELL; ARTICLE; BLAST CELL; CELL KILLING; CELL PROLIFERATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TARGETING; GENE TRANSFER; HUMAN; NONHUMAN; PERIPHERAL LYMPHOCYTE; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS; ANIMALIA;

EID: 0030751570     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.9-1125     Document Type: Article

References (35)

1. + bone marrow derived stem cells. Exp. Haem. 23, 939 (Abstract).
2. BACON, C.M., McVICAR, D.W., ORTALDO, J.R., REES, R.C., O'SHEA, J.J., and JOHNSTON, J.A. (1995a). Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J. Exp. Med. 181, 399-404.
3. BACON, C.M., PETRICOIN, E.F., 3RD, ORTALDO, J.R., REES, R.C., LARNER, A.C., JOHSTON, J.A., and O'SHEA, J.J. (1995b). Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 92, 7307-7311.
4. BRAMSON, J., HITT, M., GALLICHAN, W.S., ROSENTHAL, K.L., GAULDIE, J., and GRAHAM, F.L. (1996). Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: In vitro and in vivo production of biologically active interleukin-12. Hum. Gene Ther. 7, 333-342.
5. BRUNDA, M.J., LUISTRO, L., WARRIER, R.R., WRIGHT, R.B., HUBBARD, B.R., MURPHY M., WOLF, S.F., and GATELY, M.K. (1993). Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178, 1223-1230.
6. BULUWELA, L., FORSTER, A., BOEHM, T., and RABBITTS, T.H. (1989). A rapid procedure for colony screening using nylon filters. Nucleic Acids Res. 17, 452.
7. CHEHIMI, J., STARR, S.E., FRANK, I., RENGARAJU, M., JACKSON, S.J., LLANES, C., KOBAYASHI, M., PERUSSIA, B., YOUNG, D., NICKBARG, E., WOLF, S.F., and TRINCHIERI, G. (1992). Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175, 789-796.
8. CHIORINI, J.A., WENDTNER, C.M., URCELAY, E., SAFER, B., HALLEK, M., and KOTIN, R.M (1995). High efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high titre recombinant adeno-associated virus vectors. Hum. Gene Ther. 6, 1531-1541.
9. D'ANDREA, A., RENGARAJU, M., VALIANTE, N.M., CHEHIMI, J., KUBIN, M., ASTE, M., CHAN, S.H., KOBAYASHI, M., YOUNG, D., NICKBARG, E., CHIZZONITE, R., WOLF, S.F., and TRINCHIERI, G. (1992). Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176, 1387-1398.
10. EINERHAND, M.P.W., ANTONIOU, M., ZOLOTUKHIN, S., MUZYCZKA, N., BERNS, K.I., GROSVELD, F., and VALERIO, D. (1995). Regulated high-level human beta-globin gene expression in erythroid cells following recombinant adeno-associated virus-mediated gene transfer. Gene Ther. 2, 336-343.
11. GATELY, M.K., DESAI, B.B., WOLITZKY, A.G., QUINN, P.M., DWYER, C.M., PODLASKI, F.J., FAMILLETTI, P.C., SINIGAGLIA, F., CHIZONNITE, R., GUBLER, U., and STERN, A.S. (1991). Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147, 874-882.
12. GAZZINELLI, R.T., HIENY, S., WYNN, T.A., WOLF, S., and SHER, A. (1993). Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90, 6115-6119.
13. GUBLER, U., CHUA, A.O., SCHOENHAUT, D.S., DWYER, C.M., McCOMAS, W., MOTYKA, R., NABAVI, N., WOLITZKY, A.G., QUINN, P.M., FAMILLETTI, P.C., and GATELY, M.K. (1991). Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88, 4143-4147.
14. HATAM, L., SCHUVAL, S., and BONAGURA, V.R. (1994). Flow cytometric analysis of natural killer cell function as a clinical assay. Cytometry 16, 59-68.
15. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDON, R., SHERMAN, F., PERUSSIA, B., and TRINCHIERI, G. (1989). Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
16. KUBIN, M., KAMOUN, M., and TRTNCHIERI, G. (1994). Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 180, 211-222.
17. MANETTI, R., PARRONCHI, P., GIUDIZI, M.G., PICCINNI, M.P., MAGGI, E., TRINCHIERI, G., and ROMAGNANI, S. (1993). Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204.
18. MATTNER, F., FISCHER, S., GUCKES, S., JIN, S., KAULEN, H., SCHMITT, E., RUDE, E., and GERMANN, T. (1993). The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23, 2202-2208.
19. MILLER, J.L., DONAHUE, R.E., SELLERS, S.E., SAMULSKI, R.J., YOUNG, N.S., and NIENHUIS, A.W. (1994). Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells. Proc. Natl. Acad. Sci. USA 91, 10183-10187.
20. MU, J., ZOU, J.P., YAMAMOTO, N., TSUTSUI, T., TAI, X.G., KOBAYASHI, M., HERRMANN, S., FUJIWARA, H., and HAMAOKA, T. (1995). Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res. 55, 4404-4408.
21. MURPHY, E.E., TERRES, G., MACATONIA, S.E., HSIEH, C.S., MATTSON, J., LANIER, L., WYSOCKA, M., TRINCHIERI, G., MURPHY, K., and O'GARRA, A. (1994). B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180, 223-231.
22. MURPHY, T.L., CLEVELAND, M.G., KULESZA, P., MAGRAM, J., and MURPHY, K.M. (1995). Regulation of interleukin 12 p40 expression through an NF-κβ half-site. Mol. Cell Biol. 15, 5258-5267.
23. NASTALA, C.L., EDINGTON, H.D., McKINNEY, T.G., TAHARA, H., NALESNIK, M.A., BRUNDA, M.J., GATELY, M.K., WOLF, S.F., SCHREIBER, R.D., STORKUS, W.J., and LOTZE, M.T. (1994). Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J. Immunol. 153, 1697-1706.
24. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
25. SCOTT, P. (1993). IL-12: Initiation cytokine for cell-mediated immunity. Science 260, 496-497.
26. STERN, A.S., PODLASKI, F.J., HULMES, J.D., PAN, Y.C., QUINN, P.M., WOLITZKY, A.G., FAMILLETTI, P.C., STREMLO, D.L., TRUITT, T., CHIZZONITE, R., and GATELY, M.K. (1990). Purification to homogeneity and partial characteriation of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 87, 6808-6812.
27. SYKES, M., SZOT, G.L., NGUYEN, P.L., and PEARSON, D.A. (1995). Interleukin-12 inhibits murine graft-versus-host disease. Blood 86, 2429-2438.
28. TAHARA, H., ZEH, H.J., 3RD, STORKUS, W.J., PAPPO, I., WATKINS, S.C., GUBLER, U., WOLF, S.F., ROBBINS, P.D., and LOTZE, M.T. (1994). Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 54, 182-189.
29. TAHARA, H., ZITVOGEL, L., STORKUS, W.J., ZEH, H.J., McKINNEY, T.G., SHREIBER, R.D., GUBLER, U., ROBBINS, P.D., and LOTZE, M.T. (1995). Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol. 154, 6466-6474.
30. TAMAYOSE, K., HIRAI, Y., and SHIMADA, T. (1996). A new strategy for large scale preparation of high titre recombinant Adeno-Associated Virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum. Gene Ther. 7, 507-513.
31. WALSH, C.E., NIENHUIS, A.W., SAMULSKI, R.J., BROWN, M.G., MILLER, J.L., YOUNG, N.S., and LIU, J.M. (1994). Phenotypic correction of fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J. Clin. Invest. 94, 1440-1448.
32. WATTEL, E., VANRUMBEKE, M., ABINA, M.A., CAMBIER, N., PREUDHOMME, C., HADDADA, H., and FENAUX, P. (1996). Differential efficacy of adenoviral mediated gene transfer into cells from haematological cell lines and haematological malignancies. Leukaemia 10, 171-174.
33. WOLF, S.F., TEMPLE, P.A., KOBAYASHI, M., YOUNG, D., DICIG, M., LOWE, L., DZIALO, R., FITZ, L., FERENZ, C., HEWICK, R.M., KELLEHER, K., HERRMANN, S.H., CLARK, S.C., AZZONI, L., CHAN, S.H., TRINCHIERI, G., and PERUSSIA, B. (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146, 3074-3081.
34. ZITVOGEL, L., TAHARA, H., CAI, Q., STORKUS, W.J., MULLER, G., WOLF, S.F., GATELY, M., ROBBINS, P.D., and LOTZE, M.T. (1994). Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum. Gene Ther. 5, 1493-1506.
35. ZOU, J.J., SCHOENHAUT, D.S., CARVAJAL, D.M., WARRIER, R.R., PRESKY, D.H., GATELY, M.K., and GUBLER, U. (1995). Structure-function analysis of the p35 subunit of mouse interleukin 12. J. Biol. Chem. 270, 5864-5871.